Missing both EPS and sales estimates significantly, especially in a financial sector company like Chimera Investment, typically leads to negative investor sentiment and can result in a short-term decrease in stock price. The year-over-year decrease in sales further compounds the negative outlook, indicating potential underlying issues in the company's performance.